The company conducted the survey of 404 owners after news that the bio-pharma company Okava plans to trial a weight-loss drug for dogs that mimics the effects of weight-loss drugs like Wegovy, tapping into a potential $10 billion market.
Of the pet owners who responded, it was the younger group aged 25-34 who were most receptive to the idea of a weight-loss drug for their pet (56%).
That figure fell to 21% of 45–54-year-olds and 20% among those aged 55 and above, most of whom were probably holding up their hands in horror: "Whatever next".
Alicia Hempsted, pet insurance spokeswoman from MoneySuperMarket, said: “If GLP-1 style treatments for obesity become available for dogs in the future, it’s likely that owners will have to pay out of pocket for them, which may affect their availability."
https://www.moneysupermarket.com/pet-insurance/
Photo: www.depositphotos.com
The figures came from an analysis of over 100,000 calls made to VidiVet by owners when their normal practice was closed, between 2021 and 2024.
So far in 2024 36% of VidiVet’s calls have been gastrointestinal cases, 25% skin cases, 14% musculoskeletal and 3.7% post-surgical issues.
The advice given to many of these cases was that an emergency visit to an out-of-hours (OOH) clinic wasn’t necessary, but to monitor at home then attend their own vet practice for any workup, diagnostic tests, medication etc.
The company is now encouraging practices to consider using it's triage service over Christmas, when practices and emergency clinics often experience an increase in OOH workload.
This, it says, is a win-win situation as it relieves pressure on OOH clinics, brings revenue back to veterinary practices and also saves clients money, stress and time.
Ben Sweeney, Veterinary Surgeon, CEO and Founder of VidiVet said: “When I launched VidiVet, vet practices were understandably concerned that digital vet services could drive work away from their clinics.
"We hope this new data shows the opposite, and how it can directly benefit practices in a way they might never have imagined.
"What VidiVet has actually done, as was our belief from the get-go, is to drive the bond with clients even closer as well as providing a revenue opportunity for the practice whilst prioritising pet health and welfare.
"This is because the added benefit of a service like ours alleviates part of the immense burden on clinical teams from front of house to the surgical teams, without them losing control.
Kate Higgins MRCVS, owner of Village Vets Crosby & Formby, said: “Over the last six months we’ve saved our clients collectively an estimated £75,000 in emergency vet fees by using VidiVet.
"They were able to be reassured out-of-hours whether their pet did or didn’t need emergency treatment.
"Those that did were able to be treated swiftly by an out-of-hours clinic, and those that did need treatment but not urgently, were able to come to us during our usual working hours, not incurring emergency fees.
"What is even better for us (and our clients) is that we have the case notes from their call with VidiVet ready and waiting for us when we’re open, so we’re up to speed with what the issue has been and what advice has already been given – which is a crucial time saver for both parties.”
www.vidivet.com
Photo: Emma Paine
The recall is due to the fact that particulates have been found in identified batches of product during routine stability testing.
The affected batches are:
This issue only applies to the batches listed above. All other batches and the 20 ml pack size are not affected.
For further information regarding the recall, contact Richard Beckwith on 07584 099536 or: richard.beckwith@jurox.co.uk.
The referral centre has invested in a new heart and lung machine, and an oxygen cage, and is expected to take its first patients in the autumn.
The service will be established and led by head of cardiac surgery Poppy Bristow (pictured right) and head of cardiology Anne Kurosawa, who have already performed this kind of surgery on more than 100 dogs to date.
DWR is also setting up its own blood transfusion service to collect blood from staff and clients’ pets to support the service.
The blood collected will also be used to support the practice’s emergency and critical care service and its planned dialysis programme.
Poppy said: “There are hardly any other centres in the world offering this type of surgery, especially with this level of expertise that comes from the collective team we have gathered at DWR.
“Mitral valve disease is the most common heart condition in dogs and sadly, many dogs die every year as there are very few options for treatment. To be able to offer surgery to more dogs and their owners is really exciting.
“DWR is the perfect environment for this pioneering programme, due to the state-of-the-art equipment and depth of expertise on hand to support this life-saving initiative.”
Rob Foale, clinical director at Dick White Referrals, added: “It’s a hugely significant step for us to be launching this service, drawing on Poppy’s expertise in this field.
“We’re also starting our own blood transfusion service to complement the launch, as the pandemic has led to a huge drop in pet blood donations.
“Any excess blood we collect will be donated to the national Pet Blood Bank charity, which supplies blood to veterinary practices across the UK and does a fantastic job.”
For more information, visit www.dickwhitereferrals.com.
Alstoe Animal Health has announced that Vetergesic (buprenorphine), the UK's most commonly used injectable opiate for small animal use, is now registered for use in horses.
Developed and manufactured in the UK, Alstoe took over marketing Vetergesic 11 years ago. Two years ago the company introduced the Multi-Dose Pack, which it says allows veterinary surgeons to manage the larger liquid volumes required in horses more easily.
Alstoe says Vetergesic potentiates sedative drugs for standing sedation or routine premedication and provides profound centrally acting analgesic effects for up to nine hours. In routine procedures, this allows good recoveries and a rapid return to normal behaviour patterns.
Alstoe also says that in a thermal anti-nociceptive study carried out at Bristol University, Vetergesic showed significantly better analgesic effects than butorphanol. Field studies carried out in the UK also confirmed that when combined with a sedative, Vetergesic can provide up to 60 minutes of operating time, with smooth and quick recoveries.
John Nellis of Alstoe said: "We have invested heavily in this product and are confident that the rewards enjoyed by small animal vets will also be appreciated by their equine colleagues. We call Vetergesic 'the thoroughbred of pain management'."
Vetergesic Multidose is available for dogs, cats and horses in a 10 ml vial.
Alstoe offers an hour long explanatory seminar, which can be delivered directly to practice members. An 8 page brochure and 'pocket-sized' dose chart are also available. Further details from Alstoe on: 01347 878606 or email: info@alstoe.co.uk .
Virbac Animal Health has launched 'Spray to Win' competition in which vets who use the topical corticosteroid Cortavance between now and the end of June have the chance to win one of five Canon Ixus Cameras worth £150.
To enter the competition, ask your territory manager for a Spray to Win card, spray the pictured dog to ease his pruritus, and answer one question.
Winning cards will reveal either a camera or a 124 page manual on topical glucocorticoid therapy compiled by a group of the world's leading dermatologists.
Virbac product manager Chris Geddes MRCVS said the purpose of the campaign is to illustrate the efficacy of Cortavance as the first line treatment for all pruritic and inflammatory skin disorders: "As a potent skin-specific steroid with no detectable harmful effects¹ and competitive pricing, it's an ideal first line treatment for all atopic dermatitis cases."
There are also automatic rewards in the form of a clinical handbook on canine dermatology or a didactic atlas on canine dermatoses with every 10 bottles of Cortavance purchased, or get both with 15 bottles.
The supply of spray cards is limited, so anyone wishing to obtain a card is advised to contact their Virbac territory manager as soon as possible, or call 01359 243243.
The RCVS is inviting responses from veterinary surgeons, veterinary nurses and animal owners to a call for evidence on the provision of 24-hour emergency veterinary care, in order to understand how best to meet the expectations of all those involved.
In an open letter to the profession and the public published on the RCVS website, the Chairman of the RCVS Standards Committee, Clare Tapsfield-Wright, said:
"Over the past two years, lay people working with the RCVS have raised questions about the veterinary profession's ability to provide 24/7 to the extent required by the RCVS Code of Professional Conduct, and said there is a disconnect between the public's expectations and the profession's capacity to meet those expectations."
Clare also refers to an RCVS Disciplinary Committee Inquiry in June 2013, which raised a number of issues on home visits by veterinary surgeons, including: speed of response; travelling time and distance; daytime versus out-of-hours obligations; individual versus corporate responsibility; and, staffing levels and contingency plans.
The letter is accompanied by a range of background information, including the reports of Lay Observers to the RCVS Preliminary Investigation Committee; Working Party reports from the College's 2009 consultation on 24-hour emergency cover; and, further details about the June 2013 DC Inquiry.
The College says additional feedback will be sought through next year's RCVS Survey of the Professions, and via focus group research for animal owners. Once all responses have been collated, a number of individuals and organisations will be invited to a Standards Committee meeting to present and discuss their views.
Responses in writing are invited by 5pm on Monday, 17 February 2014, and should be emailed to 24-7@rcvs.org.uk or posted to the Professional Conduct Department, Royal College of Veterinary Surgeons, Belgravia House, 62-64 Horseferry Road, London SW1P 2AF.
The vaccine has been developed from Suvaxyn Circo+MH RTU, and also contains MetaStim as adjuvant 1.
MetaStim is an emulsion containing a metabolisable (non-mineral) oil and is used in vaccines to help elicit both humoral and a cell-mediated immune responses. Zoetis says it is thought to preserve the vaccine components so the antigens are released slowly as compared to other types of adjuvants2.
Alvaro Aldaz, Director Commercial Development and Innovation, Swine, Zoetis, said: "The safety and efficacy of MetaStim has been well documented given its use in several swine, cattle and equine vaccines for the past several years.
"In fact, the MetaStim adjuvant is currently used in our bivalent vaccine – Suvaxyn Circo+MH RTU. Suvaxyn Circo is the monovalent PCV2 fraction of the parent vaccine and it delivers a similar performance profile for PCV2 protection."
More than 250 million pigs are vaccinated against Circovirus every year in Europe.
Professor Hans Nauwynck, Director of the Laboratory of Virology at Ghent University said: "Vaccination of piglets against Circovirus has become a standard in pig farms across Europe.
"The goal is achieving strong immunity, both cell mediated and antibodies, against a virus that is always in the farm.
"Veterinarians should consider several factors when deciding the best timing for vaccination, being especially important the levels of maternal immunity in the pigs to be vaccinated, the presence of co-infections like PRRSV and the expected infection pattern in the farm."
Suvaxyn Circo is a new tool for veterinarians and producers who prefer monovalent vaccines. In situations where early vaccination of piglets against M.hyo is preferred, for example using Suvaxyn MH-One which is licensed for administration from one week of age, there will be a need to give a separate monovalent vaccine to cover PCV2. In such cases, Suvaxyn Circo from three weeks of age can be considered as an option.
Suvaxyn Circo is available in 50- and 125-dose vials.
For more information, contact your Zoetis representative.
References
Entries to the international awards came from 52 countries around the world. Each was assessed by three judges from a panel of industry leaders who are told the website's mission statement and target audience. They then visit the site, assume the role of a target user and judge according to seven criteria: design, innovation, content, technology, interactivity, copywriting and ease-of-use.
VetSurgeon.org scored the highest marks for content, interactivity and copywriting.
VetSurgeon.org Editor Arlo Guthrie said: "VetSurgeon.org was entered by our team of developers at 4Roads Ltd without me knowing about it, so this came as a very nice surprise. Particularly when you consider that other winners of a Standard of Excellence Award included the BBC, Leica, Mitsubishi Electric, Cisco, Dell, Deloitte and Philip Morris. That's very illustrious company to be in!"
Novartis Animal Health UK has announced a strategic partnership with Procter & Gamble (P&G) Pet Care, maker of the Eukanuba and Iams brands.
As part of the arrangement, the Novartis sales team will start detailing P&G's pet nutrition products to veterinary practices from April 1, 2014 in the UK and at a later stage in Ireland.
Novartis says the partnership brings together two highly complementary portfolios: Novartis is a leader in pet health areas in which P&G's Eukanuba Veterinary Diets have acknowledged strong clinical formulations, specifically dermatology, nephrology, and orthopaedic conditions. The partnership is designed to offer veterinary surgeons a holistic and flexible portfolio in key canine and feline health areas, as well as increased commercial and technical support and partnership from the Novartis sales team.
Simon Harris, sales & marketing manager at Novartis said: "Novartis Animal Health already offers expertise in key companion animal diseases together with innovative veterinary medicines. Based on research done with veterinary customers, we believe nutrition also plays an important role in disease management in pets, making our strategic cooperation with P&G Pet Care a natural fit that offers real benefits to veterinarians and their patients."
Dr. Penny Watson, Senior Lecturer in Small Animal Medicine at the University of Cambridge, said: "Clinical nutrition plays a key role in patient management and is an important complement to medicine in order to achieve a successful outcome. This combination of Eukanuba Veterinary Diets and Novartis Animal Health products helps highlight the importance of dispensing clinical diets as part of a multi-modal approach to effective patient management. Additionally, high quality nutrition is also recommended by vets as part of a normal day-to-day healthy lifestyle."
The partnership will be launched at the BSAVA Congress. The two companies say they'll have a joint presence at the event to showcase the strength and versatility of the combined Novartis and P&G Pet Care portfolio to the veterinary community.
Patricia will take up the position at the start of November, replacing Mark Ross who is stepping down.
Patricia originally joined Vets Now in 2009, working in areas of hospital management and then business development.
She became COO in June 2021.
Patricia said today: “Vets Now is made up of fantastic people and it’s the honour of my career to be leading such a talented team.
“Our out-of-hours business model was set up twenty years ago by a vet to support the working practices of vets and vet nurses, helping to improve their work-life balance by providing outstanding animal care at times of greatest need to customers. As leaders in emergency care for small animals, we’ll continue to work steadfastly in supporting the profession.
“Mark has done a tremendous job driving the business forward and I’m excited to be able to continue to build on our success. “
Vets Now says it is working hard to drive diversity and inclusion within the profession, and with 88% of Vets Now staff being female, Patricia will lead a board of directors of whom nine out of ten are women.
That doesn't sound very diverse to me.
Where are the men?
Eurovet Animal Health has launched Cardisure, a new look pimobendan which the company claims will help deliver more precise dosing in the treatment of cardiac disease.
Dogs have the widest range in bodyweight of any species, and it's long been a problem accommodating the wide variation in dosage requirements that this leads to. Having to give too many tablets in a day or the need to split small tablets can be very discouraging to owners and may lead to poorer rates of compliance.
Cardisure is available in 1.25 mg, 2.5 mg, 5 mg tablets and a 10 mg tablet size. Eurovet says the tablets are easily divisible and palatable, making it easier all round for pet owners to administer the right dose of medication to their pet.
Eurovet says the benefits of treating heart disease with pimobendan are well-established and that Cardisure gives clinicians a few more client-friendly options when it comes to treating heart disease, as well as being available in smart and professional blister packs for easy dispensing.
The materials include eye-catching waiting room bunting, wall displays, posters, leaflets and leaflet holders which offer hints and tips on how to look after pets while fireworks are going off.
Ceva is also launching a series of eight three-minute fireworks videos which offer advice to owners about how they can 'Help take the fear out of fireworks' and more information about Adaptil and Feliway. The videos are presented by Emma Carr, training and charity key account manager at Ceva Animal Health and are available to download via Vimeo and Ceva’s social media tool kit.
Veterinary practices are being encouraged to use the new materials to take part in Ceva’s annual fireworks waiting room display competition, which offers a £200 voucher for the overall best display and luxury chocolate hampers for 10 runners up (hint: entrants get additional credit if they build a display den and plug in an Adaptil Calm Home Diffuser nearby).
Practices taking part in the competition can post pictures of their dens and waiting room displays on Ceva Animal Health UK's Facebook page in October.
Abigail King, senior behaviour product manager at Ceva Animal Health, said: "The extensive marketing support we are putting behind Adaptil and Feliway in the run up to the fireworks season will help educate pet owners on the measures that can be put in place to help their pets with firework fears, while highlighting the benefits of our products."
For further information, or to request the new waiting room material, contact your local account manager or email: cevauk@ceva.com.
Zoetis, formerly Pfizer Animal Health has launched Ovatec Plus, which it claims will make equine faecal collection and in-practice worm count testing quicker and easier.
Ovatec Plus is designed to facilitate the in-house detection of worm burdens by enabling the coproscopic examination of parasite eggs, larvae and cysts. Zoetis says the built-in sample collection scoop allows for hands-off, quick, clean sample collection and controlled sample size, while the built-in cap, which can be written on for easy identification, snaps shut to seals the contents safely for contamination-free transport.
The system is based on zinc sulphate flotation technology, with a flotation time of ten minutes to provide rapid analysis. The Ova-Spin feature will break up difficult samples. The positive-locking filter chamber prevents any spill of test samples and reduces operator exposure to potential hazards. The overflow reservoir prevents overfills leaking onto the lab bench.
Zoetis says the high sensitivity and excellent specificity of Ovatec Plus enable informed treatment decisions to be made. A study has shown that samples proving negative with Ovatec Plus provide 95% certainty that the sample is <150epg and 100% certainty that the sample is <250epg, which means treatment may not be necessary1. Samples that prove positive, with one or more eggs seen, can be verified using a quantitative technique if needed, alternatively treatment may be indicated.
Ben Lacey, equine business unit manager at Zoetis, said: "Ovatec Plus is an excellent addition to our equine worm control portfolio. It's ideal for use in many test situations, giving a quick, easy and convenient solution."
To find out more, speak to your Zoetis Account Manager, call 0845 300 8034 or email CustomerSupportUK@zoetis.com.
Reference
Royal Canin highlights that obesity is one of the most common diseases that veterinary professionals face, and impacts patients' quality of life1, as well as their life expectancy2,3. Compliance is a common challenge in weight loss and even those that successfully reach their ideal weight frequently regain weight later. It therefore makes sense, says the company, to focus on prevention as well as long term management for obese cats and dogs.
Caroline Burke, Royal Canin UK Weight Management Specialist said: "Obesity is one of the most common diseases that vets and nurses see in practice, and this webinar is the latest in our programme of education around weight management. Vets and nurses will have the opportunity to learn about how they can help prevent, as well as manage obesity in practice, allowing them to truly make a difference to the lives of their patients."
Alex added: "Obesity is an ever-growing issue for cats and dogs, understanding the risks and prevention techniques is paramount for both pet owners and industry experts.
"This webinar aims to suggest how a lifelong practice monitoring programme can be implemented for the prevention of obesity. Whilst also reviewing the outcomes of weight management and defining types of prevention techniques which can be implemented."
To register for the webinar, 'How to be proactive rather than reactive for effective, preventative obesity management’, visit: https://vetportal.royalcanin.co.uk/cpd/webinar/
The company says that despite the development of alternatives to natural bone grafting, such as allografts and synthetic products, autologous bone graft is still considered the standard. However, it has a number of disadvantages, such as donor site morbidities and lameness, limited availability of graft volume (particularly in small size pets) and additional surgical time.
Biocera-Vet is a new bone substitute indicated in surgical procedures where bone grafting is necessary, such as arthrodesis, complex fractures, corrective osteotomy used in correction of limb deformities or as add-on to Tibial Tuberosity Advancement (TTA).
Biocera-Vet is an injectable synthetic self-hardening calcium-phosphate cement combining osteo-inductive, osteo-conductive and osteo-integrative properties designed to support a fast and strong consolidation.
TheraVet says Biocera-Vet also presents an excellent safety profile thanks to its biocompatibility, reduced comorbidities and superior ergonomics which save a significant amount of surgical time.
Dr Olivier Stiévenart, an orthopaedic veterinary surgeon at Surgivet in Belgium said: "Using Biocera-Vet has enabled us to optimise our patient care considerably, by reducing the operating time by at least 30 minutes. The use of an efficient and rapid bone substitute represents a real progress in terms of both operations and the animal’s quality of life".
Julie Schurgers, Chief Commercial Officer of TheraVet, said: "Biocera-Vet is a unique product on the veterinary bone substitute market, combining outstanding bone consolidation properties with an excellent safety profile and superior ergonomics. We are very excited today to announce its commercialisation on the market and are convinced that this innovative product will significantly improve the daily practices of veterinarians, for the well-being of patients and their owners."
The product is now available in Belgium, and will be rolled out in France and the Netherlands shortly, with the rest of Europe following later in 2021 / 2022.
For more information, visit: https://www.thera.vet/en/biocera-vet
VetSurgeon.org has joined forces with referral practitioner Alex Gough to conduct a survey into the profession's attitude to the use of homeopathy in animals.
Whilst the debate continues to rage over its use in human medicine, this is believed to be the first time that there has been a survey of opinion within the veterinary profession.
Alex Gough said: "This should give us an interesting insight into how practitioners feel about one of the more well-known systems of alternative medicine. That in turn may add something to the broader debate outside the veterinary profession."
Arlo said: "We really need as many veterinary surgeons as possible to take part, in order to get the most accurate picture. There are only 8 questions, and it should take less than a minute."
Click here (veterinary surgeons only), to take part in the survey.
The company says the initiative, which is targeted at veterinary professionals and farmers, will be supported by an extensive social media, advertising and PR campaign.
The social media campaign will take the form of social media content, newsletter articles and images for veterinary practices to use on their social media channels and will include information on the cost of dairy cow lameness and tips to manage lameness.
Rose Jackson BVSc DBR CertVBM MRCVS is the farm clinical director at Scarsdale Vets which has already trialled the new materials. She said: “The ‘Wave Goodbye to Pain’ social media content has ensured that we are able to post eye-catching and thought-provoking content to continue to engage with our clients and raise awareness of the ‘triple works’ approach to lameness in cows, which includes using a NSAID such as Ketofen, alongside a trim and block for a more complete recovery from lameness than trimming alone.”
The ‘Wave Goodbye to Pain’ campaign was launched following a study by Nottingham University which revealed that NSAIDs have a synergistic effect when given alongside effective hoof trimming and blocking to treat lameness1.
The study looked at claw horn disease of the hind foot and found that trimming alone resulted in a 69% rate of return to mobility without lameness in 35 days. Adding a block into an effective trimming protocol raised the success rate to 72%; trimming and administering a NSAID raised it to 76%. Interestingly, using all three techniques together - trimming, applying a block and administering an NSAID - resulted in 85% of cases being successfully resolved (Mobility score or 0 or 1).
Gemma Robinson BVM BVS MRCVS, ruminant veterinary adviser at Ceva Animal Health, said: “The study highlights that effective and prompt pain relief with NSAIDs can quickly help restore animals back to full productivity. Attitudes on the use of pain relief have changed significantly over the last 10 years and dairy farmers can have a positive influence by ensuring they recognise the value of NSAIDs and prioritise their use on-farm. It is important that vets discuss NSAIDs with their clients, both to manage illness and for routine procedures, and our ‘Wave Goodbye to Pain’ campaign will help encourage farmers to think about their current pain management plan, take action and seek help from their vet.
“Some concerns have been raised that the issues associated with antimicrobial resistance and antibiotic administration are causing farmers to avoid the use of all injectable treatments. We need to be clear that NSAIDs are anti-inflammatories, not antibiotics, and it is important they are used for pain management, fever and the clinical signs associated with many common conditions. With zero milk-withhold NSAIDs available - there really is no reason to hesitate when it comes to administering pain relief in otherwise healthy cattle.”
For more information on the ‘Wave Goodbye to Pain’ campaign visit the website designed for farmers (www.wavegoodbyetopain.co.uk), contact your local Ceva territory manager or call 01494 781510.
To request a copy of the ‘Wave Goodbye to Pain’ social media pack (including pre-developed posts and images which you can send out to your own clients), speak to your Ceva territory manager or email: cevauk@ceva.com with your name, practice name and address details.
Jane (or John) Doe was charged with having stolen midazolam, butorphanol and promethazine hydrochloride from their practice for use other than for veterinary purposes, making false clinical records concerning the use of drugs on their own dogs to disguise the fact that the drugs were instead being used for non-veterinary uses, and drawing up medication taken from the practice into a syringe for the purpose of self-medicating.
In addition, they were charged that their conduct was dishonest.
The Committee found it proven that Jane/John Doe had taken approximately 150 vials of midazolam, 87 ampoules, 112 tablets and one elixir bottle of promethazine hydrocholoride, and 0.2mls of butorphanol together with Iml of midazolam for their dog at a time when their dog was, in fact, dead.
The Committee also found it proven that the defendant had drawn up medication for the purpose of self-medicating, and had created false clinical records.
In deciding the sanction, the Committee concluded that the respondent had abused their position of trust, that their actions were dishonest, prolonged and repeated in nature, and undermined the reputation of the profession as a whole.
Therefore the only appropriate action was removal from the Register.
Unusually, the RCVS did not issue a press release about this case, as it normally does.
There was also a protracted delay between the hearing and the report of the hearing being published on the College website.
Furthermore, when it was finally published, the report had been redacted to remove any reference to the name, gender or location of the respondent.
When asked why, the College said: "Matters of a highly confidential nature arose following the hearing which led to a delay in the decisions being published.
“The decisions have been redacted and we cannot provide the reasons for the redactions as that would necessarily involve disclosure of confidential and personal information.
"However, the circumstances are considered to be exceptional and the College’s decision to make the redactions was only made following very careful consideration of evidence provided to the RCVS.
"The decision has been published on the RCVS website in its redacted form and in view of the timeframe and the circumstances, it has not been considered appropriate to issue a press release.”
CommentThe College will for sure have had very good reasons for redacting the name of the respondent in this case.
One has to assume there must have been a very real threat to the respondent’s life, and under those circumstances, confidentiality is absolutely right and proper.
However, whatever the reason, secrecy is never a good look, especially when it comes in the form of a cape worn by a regulator.
So it is frustrating to hear that the College has again made a rod for its own back, when it could so easily have included a very general one-line explanation for why it felt redaction was necessary, without compromising the individual’s confidentiality.
It would have been enough, for example, just to say that the College felt there was a risk to life. People would accept that.
The British Small Animal Veterinary Association (BSAVA) has announced that it is opening its membership to RCVS registered veterinary nurses for the first time.
BSAVA has always been keenly involved with veterinary nurse issues and has representation on the RCVS nurse Awarding Body Board and observers on VN Council. Membership Development Committee Chair Patricia Colville said: "The association strongly believes that are nurses are integral to the care the profession offers to patients, and we have always taken advice from our members on ways we can support nurses on the many issues that they have been faced with over the last number of years, from the change in nurse training to compulsory CPD and the future change to self-regulation. Now it is time to formally recognise the services we offer to VNs and bring them into a package of benefits that they can collect as a member of the Association".
Patricia added: "There have been many changes over the last 50 years, during which nurse training has developed in its own right. The depth and breadth of knowledge that nurses have, and the amount of work that they have to do to gain the VN qualification is vast and it is a great credit to the veterinary world that this level of dedication has developed. It is fantastic to see the amount of CPD on offer now and the enthusiasm and dedication that nurses show in continuing to develop their skills, which has contributed to the betterment of practice life and animal welfare".
Membership for VNs is being launched at the first year introductory price of £66 in 2011, rising to £100 per annum in 2012.
Practices interested in how BSAVA membership can support their nursing staff, and veterinary nurses interested in membership should register at http://www.bsava.com/, email administration@bsava.com or call 01452 726700.
VetFinders will recruit for permanent and locum positions for veterinary practices throughout the UK, from administration roles through to nursing staff and vets.
The agency has been founded by a man called Chris Worthington who previously built an engineering recruitment firm called Qualtech Resourcing.
Alongside Chris in the VetFinders team are recruiters Gabrielle Dawson and Martin Wilson, both with over 15 years’ experience in recruitment, Chris’s wife Anna, who is charge of accounting and payroll, and administrator Suzy Buttress.
Chris said: "VetFinders is a business with a purpose, a business with a force for good and a business with a double bottom line! Our approach is totally unique in the industry and it’s what sets us apart. Candidates are already hearing about our message and registering with VetFinders rather than other agencies.
"We have chosen four specific charities and our support for them does not stop at the point of donation. We will also be working closely with them, funding specific projects and working on their front line."
The chosen charities are:
Hope Pastures, in Leeds, which rescues, rehabilitates and re-homes horses, ponies and donkeys.
Moorview Rescue in Harrogate, which has re-homed almost 2000 dogs in the UK since it was set up as a registered charity in 2009.
Nuzzlets, a small charity based near Great Ouseburn in York which specialises in giving loving homes to unwanted animals and enabling young people free access to them for therapy and education.
Blue Cross.
When a candidate is placed by VetFinders, the client can choose which of the four charities they want a percentage of their fee to be donated to. The client and placed candidate will then be given regular updates of how their money has benefitted children and animals, including through photos, videos, emails and website updates.
For more information, visit: https://www.vetfinders.co.uk/
Photo: Top (L-R): Martin Wilson - Veterinary Recruitment Consultant, Chris Worthington - Managing Director. Bottom (L-R): Gabrielle Dawson - Veterinary Recruitment Consultant, Anna Worthington - Finance and Payroll Manager and Suzy Buttress - Administrator.
The company says the two main benefits of the liquid formulation are precise dosing and ease of administration.
Vetmedin oral solution comes with a kg-bodyweight calibrated syringe to make it easy to give the preferred dose of 0.25 mg/kg twice daily to the nearest 0.5 kg bodyweight.
The maximum syringe volume is for a 12 kg dog.
The solution has a sweet taste to make it palatable and Boehringer says it is also ideal for dogs that need dental work but require treatment for their heart disease before general anaesthesia.
These dogs might struggle to eat chewable tablets due to oral discomfort, so a liquid treatment might be a better option.
The company highlights the EPIC1 and PROTECT2 studies which showed that Vetmedin delays the onset of CHF for dogs in the asymptomatic stage of heart disease and improves both the quality and length of life for dogs with MVD and DCM.
Vetmedin oral solution comes as a 50 ml bottle (each bottle lasts a 5 kg dog approximately 30 days), doesn't need to be refrigerated, has an 8-week shelf life once opened, and a 2-year shelf life as packaged.
VetMedin oral solution is now available to order from wholesalers.
The online seminar, which equates to one hour’s CPD, features six UK experts in equine endocrinology, with the objective of supporting equine and mixed practice vets in using the clinical history to guide their interpretation of the basal ACTH test results and subsequent treatment decisions.
The speakers participating in the Equine Endocrine Pioneers Circle are:
Harry Carslake MA VetMB DipACVIM MRCVS: Senior lecturer in equine medicine at the University of Liverpool
Edd Knowles MA VetMB MVetMed DipECEIM MRCVS: Specialist in Equine internal medicine at Bell Equine Veterinary clinic
Professor Cathy McGowan BVSc DipVetClinStud MACVSc PhD DEIM DipECEIM FHEA MRCVS: Head of Department of Equine Clinical Science and Director of Veterinary Postgraduate Education at the University of Liverpool
Dr Nicola Menzies-Gow MA VetMB PhD DipECEIM Cert EM(Int Med) MRCVS: Reader in equine medicine at the Royal Veterinary College
Victoria South MA VetMB CertAVP(EM) DipECEIM MRCVS: Senior assistant at Liphook Equine Hospital
Nicola Steele BVM&S CertAVP(EM) MRCVS: Fyrnwy Equine Clinic and Director of Veterinary CPD (Equine and Large Animal)
The webinar considers when vets should test for PPID and decision-making on the best test to use, how to interpret grey zone results and also how to interpret problematic follow up tests. The experts have different opinions on some of these areas, allowing vets in practice to see the different ways in which cases can be viewed and managed.
These principles are then reinforced by the use of three clinical case scenarios with the patients all having the same basal ACTH result but a different selection of clinical signs.
Liz Barrett, equine business head at Boehringer Ingelheim said: "Since the launch of our Talk About Laminitis initiative in 2012, more than 50,000 horses have benefited from complimentary basal ACTH tests to aid the diagnosis of PPID, however two common areas of uncertainty in interpreting ACTH results still exist. Firstly, the interpretation of borderline, equivocal or ‘grey-zone’ results and when PPID treatment should or shouldn’t be recommended and secondly, the interpretation of follow-up ACTH test results and when to advise altering the treatment dose.
"The Equine Endocrine Pioneers Circle webinar allows vets to update their knowledge on this broad subject area and illustrates that there is often more than one way to approach the diagnosis, treatment and management of the PPID case."
To view the Equine Endocrine Pioneers Circle webinar on the Boehringer Academy visit https://www.boehringer-academy.co.uk/webinar/bil205
The Davies Therapy and Fitness Centre has been developed following two years of planning with the intention of supporting referring practices.
Run by a team of Chartered Veterinary Physiotherapists, hydrotherapists and anaesthetists, it has a large hydrotherapy suite, a therapeutic exercise area and gym, an outdoor exercise area, four spacious consultation and treatment rooms and a bright and airy reception.
Services include physiotherapy, rehabilitation, underwater treadmill therapy, soft supports, splinting and orthotics, fitness and conditioning and acupuncture and pain management clinics.
Good rehabilitation is pivotal to the recovery process following injury or surgery and for the management of long-term conditions such as arthritis. DVS says owners are more likely to be compliant with veterinary rehabilitation and fitness programmes if they can fully understand the importance of the process by working with a friendly, professional team, preferably at a bespoke centre.
Diane Messum, Head of Physiotherapy said: "Our mission is to work with referring practitioners to treat every pet, and their owner, with the utmost care and compassion throughout the entire veterinary process. We aim to minimise pain and restore the animals we treat to their maximum physical and mental wellbeing, with the provision of expert therapy, fitness and pain management."
To find out more visit www.vetspecialiststherapy.co.uk
Eravac is an injectable emulsion ready for administration without the need for reconstitution beforehand. Containing 10 vials with individual doses, the new presentation is is indicated for the immunisation of pet rabbits from 30 days of age.
For more information, visit: https://www.hipra.com/portal/en/hipra/animalhealth/products/detail/eravac-pets